Cracking the NLRP3 code: Pioneering precision medicine for inflammation.
Alexander N R WeberMaria Mateo TortolaJasmin B Kuemmerle-DeschnerPublished in: The Journal of experimental medicine (2024)
Precisely diagnosing and effectively treating cryopyrin-associated periodic syndrome (CAPS), an inflammatory condition linked to gain-of-function NLRP3 inflammasome mutations, poses challenges. A novel classification approach may help inform therapeutic decisions and offer valuable insights into broader inflammatory conditions (Cosson et al. J. Exp. Med. 2024. https://doi.org/10.1084/jem.20231200).